Visante released the first episode in its new Thought Leadership series, which will delve into expert views on areas including the 340B Program, sterile compounding, USP excellence and drug diversion prevention.
The first episode features Visante CEO Jim Jorgenson, who offers a look at the company’s mission and vision.
“We’re primarily composed of pharmacists, but we also have physicians, nurses, IT professionals, business and finance professionals, as well as regulatory and compliance professionals,” Jorgenson says. “We bring that complete package and level of expertise to our work to support our clients to produce optimal outcomes and results.”
To watch the first episode of the series on Visante’s website, click here.